177 related articles for article (PubMed ID: 31130787)
1. Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients.
Wagh BR; Godbole DD; Deshmukh SS; Iyer S; Deshpande PR
Indian J Crit Care Med; 2019 Apr; 23(4):170-174. PubMed ID: 31130787
[TBL] [Abstract][Full Text] [Related]
2. Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan.
Ismail M; Khan F; Noor S; Haider I; Haq IU; Ali Z; Shah Z; Hassam M
Int J Clin Pharm; 2016 Oct; 38(5):1052-6. PubMed ID: 27365090
[TBL] [Abstract][Full Text] [Related]
3. Analysis of potential drug-drug interactions in medical intensive care unit patients.
Uijtendaal EV; van Harssel LL; Hugenholtz GW; Kuck EM; Zwart-van Rijkom JE; Cremer OL; Egberts TC
Pharmacotherapy; 2014 Mar; 34(3):213-9. PubMed ID: 24390929
[TBL] [Abstract][Full Text] [Related]
4. The effect of different intensivist staffing patterns on the rate of potential drug-drug interactions in adult trauma intensive care units.
Masjedi M; Mirjalili M; Mirzaei E; Mirzaee H; Vazin A
Ther Adv Drug Saf; 2020; 11():2042098620980640. PubMed ID: 33447355
[TBL] [Abstract][Full Text] [Related]
5. Severe Potential Drug-Drug Interactions and the Increased Length of Stay of Children in Intensive Care Unit.
Lima EDC; Camarinha BD; Ferreira Bezerra NC; Panisset AG; Belmino de Souza R; Silva MT; Lopes LC
Front Pharmacol; 2020; 11():555407. PubMed ID: 33343344
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda.
Eneh PC; Hullsiek KH; Kiiza D; Rhein J; Meya DB; Boulware DR; Nicol MR
BMC Infect Dis; 2020 Aug; 20(1):572. PubMed ID: 32758158
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients.
Zhang J; Ma D; Chen M; Hu Y; Chen X; Chen J; Huang M; Dai H
Front Pharmacol; 2024; 15():1308260. PubMed ID: 38379901
[No Abstract] [Full Text] [Related]
8. Evaluation of potential drug - drug interactions in general medicine ward of teaching hospital in southern India.
Ahmad A; Khan MU; Haque I; Ivan R; Dasari R; Revanker M; Pravina A; Kuriakose S
J Clin Diagn Res; 2015 Feb; 9(2):FC10-3. PubMed ID: 25859467
[TBL] [Abstract][Full Text] [Related]
9. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
[TBL] [Abstract][Full Text] [Related]
10. Clinical decision support systems differ in their ability to identify clinically relevant drug interactions of immunosuppressants in kidney transplant patients.
Amkreutz J; Koch A; Buendgens L; Trautwein C; Eisert A
J Clin Pharm Ther; 2017 Jun; 42(3):276-285. PubMed ID: 28224645
[TBL] [Abstract][Full Text] [Related]
11. Potential drug-drug interactions in ICU patients: a retrospective study.
Ali I; Bazzar A; Hussein N; Sahhar E
Drug Metab Pers Ther; 2020 Jul; 35(3):. PubMed ID: 32681774
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevancy and risks of potential drug-drug interactions in intensive therapy.
Rodrigues AT; Stahlschmidt R; Granja S; Falcão AL; Moriel P; Mazzola PG
Saudi Pharm J; 2015 Sep; 23(4):366-70. PubMed ID: 27134536
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and nature of potential drug-drug interactions among kidney transplant patients in a German intensive care unit.
Amkreutz J; Koch A; Buendgens L; Muehlfeld A; Trautwein C; Eisert A
Int J Clin Pharm; 2017 Oct; 39(5):1128-1139. PubMed ID: 28823018
[TBL] [Abstract][Full Text] [Related]
14. Potential drug-drug interactions in cardiothoracic intensive care unit of a pulmonary teaching hospital.
Farzanegan B; Alehashem M; Bastani M; Baniasadi S
J Clin Pharmacol; 2015 Feb; 55(2):132-6. PubMed ID: 25369984
[TBL] [Abstract][Full Text] [Related]
15. Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients.
Murtaza G; Khan MY; Azhar S; Khan SA; Khan TM
Saudi Pharm J; 2016 Mar; 24(2):220-5. PubMed ID: 27013915
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of potential drug-drug interactions in intensive care unit.
Dagdelen MS; Gulen D; Ceylan I; Girgin NK
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5801-5806. PubMed ID: 34604971
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevancy and determinants of potential drug-drug interactions in chronic kidney disease patients: results from a retrospective analysis.
Saleem A; Masood I; Khan TM
Integr Pharm Res Pract; 2017; 6():71-77. PubMed ID: 29354553
[TBL] [Abstract][Full Text] [Related]
18. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria.
Noor S; Ismail M; Khadim F
Malar J; 2020 Aug; 19(1):316. PubMed ID: 32867788
[TBL] [Abstract][Full Text] [Related]
19. Drug-drug interactions in the intensive care unit: Do they really matter?
Vanham D; Spinewine A; Hantson P; Wittebole X; Wouters D; Sneyers B
J Crit Care; 2017 Apr; 38():97-103. PubMed ID: 27883969
[TBL] [Abstract][Full Text] [Related]
20. Potential Drug-Drug Interactions Among Critically Ill Pediatric Patients in a Tertiary Pulmonary Center.
Hassanzad M; Arenas-Lopez S; Baniasadi S
J Clin Pharmacol; 2018 Feb; 58(2):221-227. PubMed ID: 28834562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
